To unlock the potential from truly innovative science to transform patients’ lives

We create, build and scale companies around exceptional science to create a diversified portfolio of 20-25 globally leading healthcare businesses

Who we are

Syncona domain expertise

Our deep expertise in four key modalities enables the rapid translation of scientific research into companies with the potential to be global leaders and the development of a diversified portfolio of 20-25 companies

Making a positive contribution

We are committed to managing our business in a sustainable way, investing responsibly, and supporting our portfolio companies in making positive contributions to society by developing treatments that will make a difference to the lives of patients and their families.

2023 Annual Report front cover

2023 Annual Report

Our Annual Report and Accounts 2023 provides an overview of our most recent financial year, as we continue to deliver on behalf of our stakeholders.

28.06.23 | pdf (4.25Mb)

An expert multi-disciplinary team, attracting world-class talent

We are differentiated by our people, who identify innovative technology and take a commercial approach to building businesses capable of delivering transformational treatments to patients.

Our people

Investment team key facts

All as of 31 March 2023


Members of the investment team


Years of life science and investment expertise


Investment team with PhDs